WeVote
Log In

Bill

Bill

SB 1675

Relating to the duties of a pharmacist regarding medication profiles for high-risk patients in certain hospitals.

89th Legislature (2025) Introduced by José Menéndez and 1 co-sponsor

Texas bill requires hospital pharmacists to maintain and review medication profiles for high-risk patients to prevent dangerous drug interactions and enhance patient safety.

Co-author authorized
#hospitals(i0400) #occupationalregulation--healthoccupations(i0540) #pharmacies&pharmacists(s1192) #pharmacy #texasstateboardof(v0022)
0
WeVote Research Nonpartisan
Bill Summary · SB 1675

Legislative bill overview

SB 1675 would expand pharmacist responsibilities in Texas hospitals by requiring them to maintain and actively review comprehensive medication profiles specifically for high-risk patients. The bill appears designed to create a formal duty for pharmacists to identify potential medication safety issues through profile review before medications are dispensed or administered.

Why is this important

Medication errors and adverse drug interactions are significant sources of patient harm in hospital settings. By formally requiring pharmacists to review medication profiles for vulnerable populations, the bill aims to catch dangerous drug combinations, contraindications, and duplicative therapies before they reach patients—potentially reducing preventable hospitalizations and deaths.

Potential points of contention

  • Definition ambiguity: The bill's language regarding which patients qualify as "high-risk" and what constitutes adequate profile review could create implementation challenges and liability disputes between hospitals and pharmacists
  • Workload and staffing: Expanded pharmacist duties may require hospitals to hire additional pharmacy staff, increasing operational costs during a period of healthcare workforce shortages
  • Liability framework: Unclear whether the bill establishes clear legal boundaries for pharmacist liability when adverse events occur despite profile review, potentially exposing pharmacists or hospitals to increased malpractice claims

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.